Literature DB >> 10658944

A controlled study of the effects of isosorbide mononitrate on arterial blood pressure and pulse wave form in systolic hypertension.

G S Stokes1, M Ryan, A Brnabic, G Nyberg.   

Abstract

OBJECTIVE: To determine the effect of an extended-release nitrate preparation on the arterial pulse wave and blood pressure of patients in whom systolic blood pressure was elevated in part by exaggerated pulse-wave reflectance.
DESIGN: A double-blind randomized placebo-controlled crossover study was carried out. PATIENTS AND METHODS: The subjects were ten elderly patients with systolic hypertension resistant to conventional anti-hypertensive therapy. Pharmacodynamic responses to 2-week courses of placebo/isosorbide mononitrate (ISMN) were assessed in seven subjects by an ambulatory blood pressure monitor, and in all ten subjects by standard sphygmomanometry, arterial pulse-wave analysis and measurement of plasma nitrate concentration during peak and trough.
RESULTS: Ambulatory systolic blood pressure was decreased by ISMN (P < 0.02) between 1000 and 2200 h. Ambulatory diastolic blood pressure fell with ISMN (P < 0.01) during the last 4 h of this period. At peak plasma nitrate levels, ISMN decreased the aortic systolic blood pressure (P < 0.01), ejection peak (P < 0.02) and augmentation component (P < 0.001) of the pulse wave; heart rate increased slightly (P < 0.03).
CONCLUSION: ISMN has a role as an adjunct in the anti-hypertensive therapy of patients with refractory systolic hypertension due to exaggerated pulse-wave reflectance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658944     DOI: 10.1097/00004872-199917120-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

Authors:  S S Franklin
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Vasculopathy of Aging and the Revised Cardiovascular Continuum.

Authors:  Su-A Kim; Jeong Bae Park; Michael F O'Rourke
Journal:  Pulse (Basel)       Date:  2015-08-20

3.  Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Aaron M Secrest; Sara L Marshall; Rachel G Miller; Catherine T Prince; Trevor J Orchard
Journal:  Diabetes Technol Ther       Date:  2011-08-05       Impact factor: 6.118

4.  Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2010-09-15       Impact factor: 5.162

Review 5.  Nitrates as adjunct hypertensive treatment.

Authors:  Gordon S Stokes
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 6.  Does it matter where we measure blood pressure?

Authors:  Laurie A Tomlinson; Ian B Wilkinson
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 7.  Central blood pressure: current evidence and clinical importance.

Authors:  Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson
Journal:  Eur Heart J       Date:  2014-01-23       Impact factor: 29.983

Review 8.  Systolic hypertension in the elderly: pushing the frontiers of therapy--a suggested new approach.

Authors:  Gordon S Stokes
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

Review 9.  Why don't we use nitrates to treat older hypertensive patients?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738

10.  Effect of oral nitrates on pulse pressure and arterial elasticity in patients aged over 65 years with refractory isolated systolic hypertension: study protocol for a randomized controlled trial.

Authors:  Daniel Abad-Pérez; Blanca Novella-Arribas; Francisco J Rodríguez-Salvanés; Luis M Sánchez-Gómez; Iluminada García-Polo; Carmen Verge-González; Carmen Suárez-Fernández
Journal:  Trials       Date:  2013-11-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.